Spero Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	47.98	103.78	53.51	18.26	9.33	Upgrade
Revenue Growth (YoY)	-53.77%	93.95%	193.10%	95.67%	-48.59%	Upgrade
Cost of Revenue	96.76	51.44	47.59	64.53	67	Upgrade
Gross Profit	-48.78	52.34	5.92	-46.27	-57.67	Upgrade
Selling, General & Admin	23.7	25.55	36.48	41.7	21.44	Upgrade
Operating Expenses	23.7	25.55	36.48	41.7	21.44	Upgrade
Operating Income	-72.48	26.79	-30.57	-87.97	-79.11	Upgrade
Interest Expense	-	-	-2.61	-1.94	-	Upgrade
Interest & Investment Income	4.74	3.94	1.11	0.35	0.4	Upgrade
Currency Exchange Gain (Loss)	-	-	-	-	0.43	Upgrade
Other Non Operating Income (Expenses)	0.06	-0.01	0.86	-0.19	-	Upgrade
EBT Excluding Unusual Items	-67.69	30.71	-31.2	-89.76	-78.28	Upgrade
Merger & Restructuring Charges	-0.88	-	-11.63	-	-	Upgrade
Asset Writedown	-	-5.31	-	-	-	Upgrade
Other Unusual Items	-	-	-3.58	-	-	Upgrade
Pretax Income	-68.57	25.4	-46.42	-89.76	-78.28	Upgrade
Income Tax Expense	-	2.6	-	-	-	Upgrade
Earnings From Continuing Operations	-68.57	22.81	-46.42	-89.76	-78.28	Upgrade
Net Income	-68.57	22.81	-46.42	-89.76	-78.28	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	0.55	Upgrade
Net Income to Common	-68.57	22.81	-46.42	-89.76	-78.83	Upgrade
Shares Outstanding (Basic)	54	53	38	31	22	Upgrade
Shares Outstanding (Diluted)	54	53	38	31	22	Upgrade
Shares Change (YoY)	1.98%	40.98%	21.65%	38.01%	23.27%	Upgrade
EPS (Basic)	-1.27	0.43	-1.23	-2.91	-3.52	Upgrade
EPS (Diluted)	-1.27	0.43	-1.23	-2.91	-3.52	Upgrade
Free Cash Flow	-23.44	-33	-7.73	-64.35	-86.03	Upgrade
Free Cash Flow Per Share	-0.43	-0.62	-0.21	-2.08	-3.84	Upgrade
Gross Margin	-101.67%	50.43%	11.06%	-253.45%	-	Upgrade
Operating Margin	-151.08%	25.81%	-57.13%	-481.87%	-847.94%	Upgrade
Profit Margin	-142.91%	21.98%	-86.74%	-491.65%	-844.90%	Upgrade
Free Cash Flow Margin	-48.86%	-31.79%	-14.45%	-352.47%	-922.07%	Upgrade
EBITDA	-72.48	27.15	-29.7	-87.33	-78.35	Upgrade
EBITDA Margin	-151.08%	26.16%	-55.50%	-	-	Upgrade
D&A For EBITDA	0	0.37	0.87	0.65	0.76	Upgrade
EBIT	-72.48	26.79	-30.57	-87.97	-79.11	Upgrade
EBIT Margin	-151.08%	25.81%	-57.13%	-	-	Upgrade
Effective Tax Rate	-	10.23%	-	-	-	Upgrade
Revenue as Reported	47.98	103.78	53.51	18.26	9.33	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q